[1]苏 攀 康 毅 李 洁 郭桂伶.柴芍六君方治疗61例肝郁脾虚型溃疡性结肠炎的临床探析[J].大众科技,2022,24(08):68-71.
　Clinical Analysis on 61 Cases Of Ulcerative Colitis of Liver Depression and Spleen Deficiency Type Treated With Chaishao Liujun Formula[J].Popular Science & Technology,2022,24(08):68-71.
点击复制

柴芍六君方治疗61例肝郁脾虚型溃疡性结肠炎的临床探析()
分享到：

《大众科技》[ISSN:1008-1151/CN:45-1235/N]

卷:
24
期数:
2022年08
页码:
68-71
栏目:
医药与卫生
出版日期:
2022-08-20

文章信息/Info

Title:
Clinical Analysis on 61 Cases Of Ulcerative Colitis of Liver Depression and Spleen Deficiency Type Treated With Chaishao Liujun Formula
作者:
苏 攀1 康 毅1 李 洁1 郭桂伶2　
（1.广西中医药大学第一附属医院，广西 南宁 530023； 2.南宁市第四人民医院，广西 南宁 530023）
关键词:
肝郁脾虚型; 溃疡性结肠炎; 加味柴芍六君; 美沙拉嗪; 临床研究
Keywords:
liver depression and spleen deficiency type ulcerative colitis flavored Chaishao Liujun mesalazine clinical research
文献标志码:
A
摘要:
目的：探析柴芍六君方在临床上对肝郁脾虚型溃疡性结肠炎治疗的疗效。方法：研究病例随机分组共计61例，其中31名中药柴芍六君方治疗组和30名美沙拉嗪对照组，对比评价两组药物在治疗该病肝郁脾虚型的治疗效果及不良反应。治疗前后评价两组病例肠镜的粘膜疗效、总体治疗有效率、肠道粘膜病理变化、主要症状及评分、IBDQ评分、患者生存质量和不良药物反应。结果：治疗后柴芍六君方组在总体治疗有效率、肠镜的粘膜疗效、肠道粘膜病理变化均优于美沙拉嗪组（P＜0.05）；柴芍六君方组在缓解患主要症状及评分上中药优于美沙拉嗪组（P＜0.05）；治疗后柴芍六君方组在IBDQ评分、患者生存质量上的积分改善明显（P＜0.01）；两组不良药物反应中药治疗组较低（P＜0.05）。结论：在治疗肝郁脾虚型溃疡性结肠炎中药加味柴芍六君治疗疗效显著，能改善患者的生存质量，降低药物不良反应的发生，比单用美沙拉嗪更具优势。
Abstract:
Objective: To explore the clinical efficacy of Chaishao Liujun formula in the treatment of ulcerative colitis with liver stagnation and spleen deficiency type. Methods: A total of 61 cases were randomly divided into two groups, including 31 cases in the traditional Chinese medicine Chaishao Liujun formula treatment group and 30 cases in the mesalazine control group. The therapeutic effects and adverse reactions of the two groups in the treatment of liver depression and spleen deficiency type of this disease were compared and evaluated. Before and after treatment, the mucosal curative effect, overall effective rate, pathological changes of intestinal mucosa, main symptoms and scores, IBDQ score, quality of life and adverse drug reactions were evaluated. Results: After treatment, Chaishao Liujun formula group was superior to mesalazine group in the overall therapeutic efficiency, enteroscopic mucosal efficacy, and pathological changes of intestinal mucosa (P<0.05). Chaishao Liujun formula group was superior to mesalazine group in relieving main symptoms and scoring (P<0.05) after treatment, the IBDQ score and quality of life of patients in the Chaishao Liujun formula group were significantly improved (P<0.01) the adverse drug reactions of the two groups were lower in the traditional Chinese medicine treatment group (P<0.05). Conclusion: In the treatment of ulcerative colitis of liver depression and spleen deficiency type, the modified Chaishao Liujun has significant curative effect. It can improve the quality of life of patients and reduce the occurrence of adverse drug reactions. It has more advantages than mesalazine alone.

参考文献/References:

[1] 杨钊斌，杨川华，钱本余. 2010年世界胃肠病学组织关于炎症性肠病诊断和治疗的实践指南[J]. 胃肠病学，2010，15(9): 548-558. [2] 左振魁，韩佳瑞. 中西医结合治疗溃疡性结肠炎的临床研究[J]. 世界中医药，2017，12(6): 1347-1349，1353. [3] 范一宏，王诗怡. 治疗的艺术:重视炎症性肠病患者的心理健康[J]. 世界华人消化杂志，2016，24(16): 2445-2453. [4] 王新月，王建云. 溃疡性结肠炎中医药治疗的关键问题与优势对策[J]. 中华中医药杂志，2012(2): 263-267. [5] 谢晶日，林静. 肠澼源流探微[J]. 新中医，2010，42(10): 7-8. [6] 朱磊，沈洪，顾培青，等. 溃疡性结肠炎中医病名探讨[J]. 中医学报，2013(3): 416-417. [7] 张艳红. 历代医家对休息痢的认识[J]. 河北中医，2007，29(6): 547-548. [8] 吴开春，梁洁，冉志华，等. 炎症性肠病诊断与治疗的共识意见(2018年北京)[J]. 中国实用内科杂志，2018，38(9): 796-813. [9] 张艳彬. 活动期溃疡性结肠炎的中医证候与结肠镜下的黏膜象表现的关系探讨[J]. 现代中西医结合志，2019，28(1): 89-92，106. [10] 陈治水，危北海，张万岱，等. 溃疡性结肠炎中西医结合诊疗指(草案)[J]. 中国中西医结合消化杂志，2011(1): 61-65. [11] 杨钊斌，杨川华，钱本余. 2010年世界胃肠病学组织关于炎症性肠病诊断和治疗的实践指南[J]. 胃肠学，2010(9): 548-558. [12] 郑家驹. 炎症性肠病基础与临床[M]. 北京: 科学出版社，2001. [13] 郭雁冰，王新月，林燕. 中药抗溃疡性结肠炎复发的临床观察[J]. 中华中医药学刊，2008(2): 438-440. [14] 江学良，权启镇，王志奎. 溃疡性结肠炎的诊断、分型及疗效标准[J]. 世界华人消化杂志，2000(3): 332-334. [15] 邓长生，夏冰. 炎症性肠病[M]. 北京: 人民卫生出版社，1998. [16] 张声生. 溃疡性结肠炎中医诊疗共识意见[J]. 中华中医药杂志，2010，25(6): 891-895.

相似文献/References:

[1]何 佳,李 晶.中医治疗溃疡性结肠炎的研究进展[J].大众科技,2019,21(08):90.
　Advances in the Treatment of Ulcerative Colitis with Traditional Chinese Medicine[J].Popular Science & Technology,2019,21(08):90.
[2]萧慧莹 杜铭君.溃疡性结肠炎的中医药临床研究进展[J].大众科技,2020,22(09):84.
　Clinical Research Progress of Traditional Chinese Medicine in Ulcerative Colitis[J].Popular Science & Technology,2020,22(08):84.
[3]郭德炜 韦熔煌 陈泉亨 刘春强.基于JAK/STAT信号通路探讨中医药在溃疡性结肠炎中的应用[J].大众科技,2023,25(10):81.
　Discussion on the Application of Traditional Chinese Medicine in Ulcerative Colitis Based on JAK/STAT Signaling Pathway[J].Popular Science & Technology,2023,25(08):81.
[4]卢 鑫 杨星星 吕 哲 林逸婷 张馨月.基于“肾主二便”理论探析中医治疗溃疡性结肠炎[J].大众科技,2021,23(7):61.
　Analysis of the Treatment of Ulcerative Colitis by Traditional Chinese Medicine Based on the Theory of "Kidney Controlling Urination and Defecation"[J].Popular Science & Technology,2021,23(08):61.
[5]李 炜 黄菊芳 罗茂权 黎敏航 罗 婷 罗伟生.中西医结合治疗溃疡性结肠炎的研究进展[J].大众科技,2021,23(10):90.
　Research Progress of Integrated Traditional Chinese and Western Medicine in the Treatment of Ulcerative Colitis[J].Popular Science & Technology,2021,23(08):90.
[6]施智兰,唐梅文,农复香,等.中医药治疗溃疡性结肠炎的研究进展[J].大众科技,2023,25(2):95.
　Research Progress of Traditional Chinese Medicine in Treating Ulcerative Colitis[J].Popular Science & Technology,2023,25(08):95.

备注/Memo

备注/Memo:
【收稿日期】2022-06-14 【基金项目】广西卫生和计划生育委员会自筹课题（Z20180531）。 【作者简介】苏攀（1987－），男，广西中医药大学第一附属医院主治医师，研究方向为中医药防治脾胃病。
更新日期/Last Update: 2022-09-19